EREG and breast carcinoma: Consistent with these findings, previous studies have shown that EGFR ligands, such as EREG and HBEGF, stimulate breast cancer cell transendothelial migration, while EGFR inhibition promotes survival following introduction of brain homing breast cancer cells into the circulation in vivo6.